Filing Details
- Accession Number:
- 0001415889-22-011878
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-01 16:16:00
- Reporting Period:
- 2022-11-29
- Accepted Time:
- 2022-12-01 16:16:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1730430 | Kiniksa Pharmaceuticals Ltd. | KNSA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1384243 | D Barry Quart | C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM 11 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Common Share | Acquisiton | 2022-11-29 | 21,959 | $1.59 | 21,959 | No | 4 | M | Direct | |
Class A Common Share | Disposition | 2022-11-29 | 21,959 | $16.15 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Class A Common Share | Share Option | Disposition | 2022-11-29 | 21,959 | $0.00 | 21,959 | $1.59 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2025-12-15 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $16.09 to $16.25. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Class A Common Shares sold at each price.
- The option is fully vested and exercisable.